Atika Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 78 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 79 |
|
|
2024
Q1 | – | Sell |
-9,000
| Closed | -$363K | – | 88 |
|
|
2023
Q4 | $363K | Buy |
+9,000
| New | +$363K | 0.05% | 69 |
|
|
2023
Q2 | – | Sell |
-90,000
| Closed | -$1.49M | – | 72 |
|
|
2023
Q1 | $1.49M | Buy |
+90,000
| New | +$1.49M | 0.22% | 68 |
|
|
2021
Q4 | – | Sell |
-73,500
| Closed | -$3.45M | – | 79 |
|
|
2021
Q3 | $3.45M | Buy |
73,500
+1,100
| +2% | +$51.6K | 0.21% | 88 |
|
|
2021
Q2 | $4.41M | Sell |
72,400
-5,000
| -6% | -$305K | 0.35% | 75 |
|
|
2021
Q1 | $4.77M | Buy |
77,400
+6,600
| +9% | +$406K | 0.41% | 67 |
|
|
2020
Q4 | $5.04M | Buy |
70,800
+8,300
| +13% | +$590K | 0.39% | 71 |
|
|
2020
Q3 | $2.35M | Sell |
62,500
-42,300
| -40% | -$1.59M | 0.19% | 82 |
|
|
2020
Q2 | $3.42M | Sell |
104,800
-4,700
| -4% | -$153K | 0.44% | 67 |
|
|
2020
Q1 | $3.18M | Buy |
109,500
+81,200
| +287% | +$2.36M | 0.61% | 45 |
|
|
2019
Q4 | $991K | Buy |
+28,300
| New | +$991K | 0.19% | 66 |
|